DENVER--(BUSINESS WIRE)--TranS1, a medical device company that develops products to solve spinal pathologies, named Brandon Arthurs vice president of research and development. In this role, Arthurs, a certified professional engineer, will lead collaborations with surgeons and entrepreneurs to bring medical innovations to market. This will include products that complement TranS1’s flagship spinal fusion device, the AxiaLIF+ system.
Arthurs brings nearly two decades of successful technical leadership and product development, as well as an extensive track record of securing medical patents. Arthurs returns to TranS1, where he previously served in various capacities, including director of research and development, engineering manager, and senior R&D engineer. He also worked as a principal project engineer with the Wrightsville Consulting Group. Arthurs earned his Bachelor’s Degree from North Carolina State University and an A.S. from Gaston College.
“It is TranS1’s mission to give surgeons the tools to develop and bring to market medical breakthroughs,” said Jeff Schell, CEO of TranS1. “Brandon’s prior experience with the TranS1 brand and its products, coupled with his extensive relationships with surgeons, make him a huge asset.”
Arthurs will manage a team comprised of inventors, physicians, engineers, Ph.D.s, and patent attorneys. Additionally, he will work directly with TranS1’s Surgeon Advisory Board and surgeons to lead physician-driven innovation and research and development (R&D) efforts.
“I have worked with Brandon Arthurs for more than a decade, and he is a very talented and seasoned product engineer with a knack for integrating the concerns of his surgeons with the necessities of design,” said Gary Fleischer, M.D., the head of the New England Neck & Spine Institute and a leading surgeon. “He will make a fantastic vice president of research and development, bringing his experience, maturity, and temperament to the job and inspiring a team of skilled coworkers.”
About TranS1
TranS1 develops products to solve spinal pathologies while minimizing trauma to the tissues surrounding the spine. The company’s flagship product, AxiaLIF, is a minimally invasive option for surgeons to accomplish spinal fusion at the L5-S1 joint. AxiaLIF achieves a faster recovery time, cost savings, and lower incidence of complication compared to alternative procedures.